NCT01771471View on ClinicalTrials.gov

A Study Comparing the Safety and Effectiveness of Cartilage Cell Injected Into the Lumbar Disc as Compared to a Placebo

PHASE2TerminatedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions
Degenerative Disc Disease
Interventions
BIOLOGICAL

NuQu

Allogenic juvenile chondrocytes (NuQu) in fibrin carrier.

OTHER

Placebo

0.9% w/v Sodium Chloride for Injection, USP

Trial Locations (10)

10065

Weill Cornell Medical College, New York

20190

Spinal Reseach Foundation, Reston

28204

Carolina Neurosurgery and Spine Associates, Charlotte

31210

Ortho Georgia, Macon

35235

Alabama Orthopedic and Spine Center, Birmingham

76092

Spine Team Texas, Southlake

79401

The NeuroSpine Institute, Eugene

90403

The Spine Institute, Center for Spinal Restoration, Santa Monica

94115

California Spine Diagnostics, San Francisco

02458

Tufts University School of Medicine, Newton

Sponsors
All Listed Sponsors
lead

ISTO Technologies, Inc.

INDUSTRY